|
Amorfix closes private placement and receives back rights for ALS antibody …
Canada NewsWire (press release) … Oct. 21, 2014 /CNW/ – Amorfix Life Sciences Ltd. (the “Corporation”) announces today that it has closed the first tranche of a non-brokered private placement (the Offering) pursuant to which 1,260,000 common shares of Amorfix (Shares) and 1,260,000 … |
